Few events shatter new parents' joy faster than learning that their baby has an incurable illness. One such condition is infantile Krabbe's disease, an inherited disorder of the nervous system. Because of an enzyme deficiency, the short lives of such infants are marked by irritability, feeding problems, seizures, blindness, and deafness. These babies usually die before age 2.
Doctors now report rescuing infants from Krabbe's disease with an infusion of umbilical cord blood from an unrelated donor.
Pediatrician Maria L. Escolar of the University of North Carolina at Chapel Hill and her colleagues there and at Duke University Medical Center in Durham, N.C., identified 11 babies before or soon after birth who had the enzyme deficiency but hadn't yet shown signs of Krabbe's disease. They also identified 14 other babies, ages 4 to 9 months, who lacked the enzyme but already showed symptoms of disease. The doctors gave all the children a drug that wipes out bone marrow and, a week or so later, transfused each baby with a dose of cord blood.
Follow-up ranging from a few months to nearly 6 years shows that all 11 participants who were treated as newborns are still alive, and 7 have passed their second birthdays. However, 8 of the 14 babies who received cord blood after showing symptoms of disease have died, the researchers report in the May 19 New England Journal of Medicine.
Moreover, the babies treated as newborns have shown normal vision and only two scored below normal on cognitive-development tests. Some exhibit motor-skills deficits such as problems walking.
In contrast, all the surviving children who received cord blood after showing signs of Krabbe's disease are severely disabled.
Because they lack the enzyme called galactocerebrosidase, children with Krabbe's disease fail to produce and maintain myelin, the fatty substance that insulates nerve fibers. Stem cells in transplanted bone marrow can grow into brain cells that produce galactocerebrosidase. However, locating a matching marrow donor is sometimes a lengthy process.
Finding a cord-blood donor is quicker. Cord-blood transplants don't need to come from as closely matched a donor as marrow cells do, says Escolar, and the donor doesn't require surgery.
Furthermore, cord-blood stem cells seem to establish themselves in the brain more reliably than marrow stem cells do, Escolar says.
"It's not often we get to see such an important piece of work," says geneticist Pablo Rubinstein of the New York Blood Center. Escolar's findings suggest that doctors should screen all newborns for Krabbe's disease, Rubinstein says. "We shouldn't be waiting until we have cause" to look for it, he adds.
Maria L. Escolar
Center for the Study of Development and Learning
University of North Carolina, Chapel Hill
Chapel Hill, NC 27599-7255
New York Blood Center
310 East 67th Street
New York, NY 10021
Krivit, W., et al. 1998. Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. New England Journal of Medicine 338(April 16):1119-1126. Available at [Go to].
Kurtzberg, J. . . . and P. Rubinstein. 1996. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. New England Journal of Medicine 335(July 18):157-166. Available at [Go to].
Rafi, M.A., et al. 1995. A large deletion together with a point mutation in the GALC gene is a common mutant allele in patients with infantile Krabbe disease. Human Molecular Genetics 4(August):1285-1289. Abstract available at [Go to].
Rubinstein, P., et al. 1998. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. New England Journal of Medicine 339(Nov. 26):1565-1577. Available at [Go to].
Seppa, N. 2004. Umbilical bounty: Cord blood shows value against leukemia. Science News 166(Nov. 27):339. Available to subscribers at [Go to].
______. 2004. Cord blood to the rescue: Infusions help babies with Herler's syndrome. Science News 165(May 8):293. Available to subscribers at [Go to].
______. 2003. Double cord-blood transplant helps cancer patients. Science News 163(Jan. 4):14. Available to subscribers at [Go to].
Weinberg, K.I. 2005. Early use of drastic therapy. New England Journal of Medicine 352(May 19):2124-2126. Extract available at [Go to].
For additional information about Krabbe's disease, go to [Go to].